Dylan Hartley - 04 Oct 2024 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Role
Chief Scientific Officer
Signature
/s/ Rogan Nunn, by power of attorney
Issuer symbol
OKUR
Transactions as of
04 Oct 2024
Net transactions value
$0
Form type
4
Filing time
08 Oct 2024, 19:24:46 UTC
Next filing
29 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OKUR Employee Stock Option (right to buy) Award $0 +137,603 $0.000000 137,603 04 Oct 2024 Class A Common Stock 137,603 $18.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on June 9, 2025 and 1/48th of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.